Pfizer Inc. PFE is likely to boost its offer for British drug maker AstraZenica AZN to $96.28 a share, an analyst said Tuesday.
SunTrust's John Boris said a deal would cut Pfizer's tax rate to 20 percent and said potential Treasury inversion action blocking such action is merely “election year rhetoric.”
The $127 billion offer envisioned by Boris would tack on 6.3 percent to its earlier bid of $120 billion takeover offer, which AstraZenica rejected back in mid-May
AstraZeneca's American Depositary Receipts were recently down 2 percent at $74.62 from Friday's high but were still up nearly 26 percent for the year.
Under British rules, AstraZeneca can starting Tuesday invite it back for talks or Pfizer can make a single "knock-out" bid which it believes would be accepted. Or Pfizer can start a more conventional bidding process over again beginning in November.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in